Long-term, low-dosage, trimethoprim-sulphonamide in the control of chronic bacteriuria.

PubWeight™: 1.01‹?› | Rank: Top 15%

🔗 View Article (PMID 5361312)

Published in Postgrad Med J on November 01, 1969

Authors

F O'Grady, D A Chamberlain, J E Stark, W R Cattell, J M Sardeson, I F Fry, F I Spiro, A H Waters

Articles by these authors

Career prospects in cardiology in England and Wales. Survey and 15 health regions. Br Heart J (1981) 8.82

Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet (2002) 8.10

Survey of 3765 cardiopulmonary resuscitations in British hospitals (the BRESUS Study): methods and overall results. BMJ (1992) 6.82

Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. A statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation (1991) 5.17

Effects of atropine on heart-rate in healthy man. Lancet (1967) 5.10

Plasma digoxin concentrations in patients with atrial fibrillation. Br Med J (1970) 4.82

Comparison of the responses of Escherichia coli and proteus mirabilis to seven beta-lactam antibodies. J Infect Dis (1973) 4.44

The effect of osmolality on the response of Escherichia coli and Proteus mirabilis to penicillins. Br J Exp Pathol (1972) 3.96

A community training scheme in cardiopulmonary resuscitation. Br Med J (Clin Res Ed) (1984) 3.83

A milestone for myocardial infarction. BMJ (1988) 3.42

Trimodal response of Escherichia coli and Proteus mirabilis to penicillins. Nature (1970) 3.12

A twelve channel bacterial growth monitoring system. Biomed Eng (1973) 3.07

A comparison of the effects of ampicillin on Escherichia coli and proteus mirabilis. J Med Microbiol (1969) 2.97

FL 1060: a new beta-lactam antibiotic with novel properties. J Clin Pathol (1973) 2.95

Kinetics of urinary tract infection. II. The bladder. Br J Urol (1966) 2.89

The Brighton resuscitation ambulances: a continuing experiment in prehospital care by ambulance staff. Br Med J (1976) 2.66

Mobile coronary care provided by ambulance personnel. Br Med J (1973) 2.55

Hospital resuscitation from ventricular fibrillation in Brighton. Br Med J (1979) 2.43

Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol (1987) 2.34

Uropathogenic properties of Escherichia coli in recurrent urinary-tract infection. J Med Microbiol (1980) 2.28

Guidelines for Cardiopulmonary Resuscitation. Advanced life support. Revised recommendations of the Resuscitation Council (UK) BMJ (1989) 2.25

The Brighton resuscitation ambulances: review of 40 consecutive survivors of out-of-hospital cardiac arrest. Br Med J (1978) 2.24

Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style. Task Force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Ann Emerg Med (1991) 2.22

Potent combinations of beta-lactam antibiotics using the beta-lactamase inhibition principle. Chemotherapy (1975) 2.19

Reduction in hospital time to thrombolytic therapy by audit of policy guidelines. Eur Heart J (1990) 2.17

Diagnostic accuracy of cytology and biopsy in primary bronchial carcinoma. Thorax (1979) 1.95

Treatment of "bacterial cystitis" in fully automatic machanical models simulating conditions of bacterial growth in the urinary bladder. Br J Exp Pathol (1973) 1.95

Ventricular arrhythmias caused by prenylamine. Br Med J (1977) 1.92

Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91

Automation of the assay of folate in serum and whole blood. J Clin Pathol (1970) 1.90

Haemodynamic effects of salbutamol in patients with acute myocardial infarction and severe left ventricular dysfunction. Br Med J (1979) 1.82

The responses of Escherichia coli to nalidixic acid. Chemotherapy (1978) 1.78

In-flight deaths during commercial air travel. How big is the problem? JAMA (1988) 1.78

The two sites of penicillin action in Escherichia coli. J Infect Dis (1973) 1.71

Five hundred patients with myocardial infarction monitored within one hour of symptoms. Br Med J (Clin Res Ed) (1983) 1.71

Diagnostic accuracy of cytology and biopsy in primary bronchial carcinoma. J Clin Pathol (1981) 1.69

Iron metabolism in patients undergoing regular dialysis therapy. Br Med J (1971) 1.67

An in vitro model of the urinary bladder. J Antimicrob Chemother (1978) 1.62

Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency. Antimicrob Agents Chemother (1980) 1.61

Amiodarone increases plasma digoxin concentrations. Br Med J (Clin Res Ed) (1981) 1.61

Introital enterobacteria, urinary infection, and the urethral syndrome. Lancet (1970) 1.60

The comparative performance of beta-lactam antibiotics against ampicillin sensitive Escherichia coli in conditions simulating those of the infected urinary bladder. Br J Exp Pathol (1974) 1.60

Cephalosporin-induced immune neutropenia. Br J Haematol (1985) 1.56

Renal function after high dose urography in patients with renal failure. Br J Radiol (1981) 1.52

Iatrogenic osteomalacia and myopathy due to phosphate depletion. Br Med J (1974) 1.51

Experimental chloroquine myopathy. J Neurol Neurosurg Psychiatry (1966) 1.50

Resistance categories of enterobacteria to beta-lactam antibiotics. J Infect Dis (1975) 1.47

Dextrose and sorbitol as diluents for continuous intravenous heparin infusion. Br Med J (1972) 1.46

Beta adrenoceptor antagonists after myocardial infarction--where are we now? Br Heart J (1983) 1.45

HPA-1 typing by PCR amplification with sequence-specific primers (PCR-SSP): a rapid and simple technique. Br J Haematol (1993) 1.42

Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol (1987) 1.42

Activity and interaction of trimethoprim and sulphamethoxazole against Escherichia coli. J Clin Pathol (1976) 1.41

Apparent removal of graft-versus-leukaemia effect by the use of leucocyte-poor blood components in patients with acute myeloblastic leukaemia. Br J Haematol (1989) 1.40

Development and further applications of a simple turbidity cell for continuously monitoring bacterial growth. Phys Med Biol (1973) 1.40

Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction. BMJ (1989) 1.39

Mental symptoms presenting in phaeochromocytoma: a case report and review. J R Soc Med (1988) 1.39

Personality characteristics of South African navy divers. Undersea Hyperb Med (2001) 1.38

Renal disease. II. Urinary tract infection in women. J R Coll Physicians Lond (1997) 1.37

The nephrographic pattern during excretion urography. Br Med Bull (1972) 1.36

Plasma concentrations of digoxin after oral administration in the fasting and postprandial ste. Br Med J (1971) 1.36

The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase by patients with renal disease. Clin Chim Acta (1970) 1.35

High-dose intravenous IgG in adults with autoimmune thrombocytopenia. Lancet (1983) 1.34

Use of an automated external defibrillator-pacemaker by ambulance staff. Lancet (1982) 1.33

Beta-adrenergic blockade in angina pectoris: a method of treadmill assessment. Br Med J (1966) 1.32

The response of Staphylococcus aureus to benzylpenicillin. Br J Exp Pathol (1979) 1.31

Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina. J Am Coll Cardiol (2000) 1.31

Amiodarone in the treatment of refractory supraventricular and ventricular arrhythmias. Postgrad Med J (1979) 1.31

Effects of beta adrenergic blockade on heart size. Am J Cardiol (1966) 1.31

Diffuse interstitial renal tuberculosis--an unusual cause of renal failure. Q J Med (1981) 1.29

Estimation of residual urine volume with 131 I-hippuran. Br J Urol (1968) 1.28

Effect of diuresis and frequent micturition on the bacterial content of infected urine: a measure of competence of intrinsic hydrokinetic clearance mechanisms. Br J Urol (1970) 1.28

Guidelines for platelet transfusions. British Committee for Standards in Haematology, Working Party of the Blood Transfusion Task Force. Transfus Med (1992) 1.27

Bromhexine and mucociliary clearance in chronic bronchitis. Br J Dis Chest (1974) 1.27

Bilateral Upper Thoracic Sympathectomy in Angina Pectoris: Results in 52 Cases. Br Med J (1965) 1.25

Sequential atrioventricular pacing in heart block complicating acute myocardial infarction. N Engl J Med (1970) 1.25

Trimethoprim R plasmids isolated during long-term treatment of urinary tract infection with co-trimoxazole. J Antimicrob Chemother (1979) 1.25

R plasmids from Asian strains of Vibrio cholerae. Antimicrob Agents Chemother (1977) 1.25

Scanning electron microscopy of Staphyloccus aureus exposed to some common anti-staphylococcal agents. J Gen Microbiol (1972) 1.25

Excretion urography. I. Factors determining the excretion of Hypaque. Br J Radiol (1967) 1.24

Simple mechanical methods for cardioversion: defence of the precordial thump and cough version. Br Med J (Clin Res Ed) (1985) 1.22

Ammonia production by intestinal bacteria. Gut (1973) 1.21

Resistance to antimicrobial agents of Vibrio cholerae E1 Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull World Health Organ (1980) 1.21

Cephalexin levels in human bile in presence of biliary tract disease. Br Med J (1972) 1.19

Policy for early discharge after acute myocardial infarction. Br Med J (1980) 1.19

Potassium depletion in severe heart disease. Br Med J (1969) 1.19

Comparison of haemodynamic responses to dopamine and salbutamol in severe cardiogenic shock complicating acute myocardial infarction. Br Med J (Clin Res Ed) (1981) 1.19

Death in the clouds. Br Med J (Clin Res Ed) (1987) 1.18

The excretion of N-acetyl-beta-glucosaminidase and beta-galactosidase following surgery to the kidney. Clin Chim Acta (1970) 1.18

High-dose excretion urography in oliguric renal failure. Lancet (1970) 1.15

The effect of lactulose on the faecal flora of patients with hepatic encephalopathy. J Med Microbiol (1974) 1.13

Antiobiotics in renal failure. Br Med Bull (1971) 1.13

Digitalis: where are we now? Br Heart J (1985) 1.11

Global surveillance of antibiotic sensitivity of Vibrio cholerae. Bull World Health Organ (1976) 1.11

Bacterial growth in an in vitro system simulating conditions in the urinary bladder. Br J Exp Pathol (1966) 1.11